CO5560586A2 - Acido n-(5-clorosaliciloil)-8-aminocaprilico como agente de suministro oral para fragmentos de hormona paratiroides - Google Patents
Acido n-(5-clorosaliciloil)-8-aminocaprilico como agente de suministro oral para fragmentos de hormona paratiroidesInfo
- Publication number
- CO5560586A2 CO5560586A2 CO04013136A CO04013136A CO5560586A2 CO 5560586 A2 CO5560586 A2 CO 5560586A2 CO 04013136 A CO04013136 A CO 04013136A CO 04013136 A CO04013136 A CO 04013136A CO 5560586 A2 CO5560586 A2 CO 5560586A2
- Authority
- CO
- Colombia
- Prior art keywords
- pth
- pharmaceutical composition
- composition according
- acid
- chlorosaliciloil
- Prior art date
Links
- 239000012634 fragment Substances 0.000 title abstract 3
- 239000002253 acid Substances 0.000 title abstract 2
- 239000003795 chemical substances by application Substances 0.000 title 1
- 239000005556 hormone Substances 0.000 title 1
- 229940088597 hormone Drugs 0.000 title 1
- 108090000445 Parathyroid hormone Proteins 0.000 abstract 14
- 102100036893 Parathyroid hormone Human genes 0.000 abstract 12
- 239000008194 pharmaceutical composition Substances 0.000 abstract 8
- XRTHAPZDZPADIL-UHFFFAOYSA-N 8-[(5-chloro-2-hydroxybenzoyl)amino]octanoic acid Chemical compound OC(=O)CCCCCCCNC(=O)C1=CC(Cl)=CC=C1O XRTHAPZDZPADIL-UHFFFAOYSA-N 0.000 abstract 3
- OGBMKVWORPGQRR-UMXFMPSGSA-N teriparatide Chemical compound C([C@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](N)CO)C(C)C)[C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=1N=CNC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1N=CNC=1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CNC=N1 OGBMKVWORPGQRR-UMXFMPSGSA-N 0.000 abstract 3
- 101001135770 Homo sapiens Parathyroid hormone Proteins 0.000 abstract 2
- 101001135995 Homo sapiens Probable peptidyl-tRNA hydrolase Proteins 0.000 abstract 2
- 102000003982 Parathyroid hormone Human genes 0.000 abstract 2
- 102000058004 human PTH Human genes 0.000 abstract 2
- 239000000199 parathyroid hormone Substances 0.000 abstract 2
- 108700000288 parathyroid hormone (1-28) Proteins 0.000 abstract 2
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical class [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 abstract 1
- 108010049264 Teriparatide Proteins 0.000 abstract 1
- 150000004682 monohydrates Chemical class 0.000 abstract 1
- 108010073509 parathyroid hormone (1-31) Proteins 0.000 abstract 1
- 108010073230 parathyroid hormone (1-38) Proteins 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
- A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/29—Parathyroid hormone (parathormone); Parathyroid hormone-related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
Abstract
1.- Una composición farmacéutica para suministro oral, que comprende una cantidad terapéuticamente efectiva de un fragmento de PTH y 5-CNAC, dicho fragmento de PTH seleccionado de PTH (1-28) a PTH (1-41).2.- Una composición farmacéutica de acuerdo con la reivindicación 1, en donde la PTH se selecciona de PTH (1-28), PTH (1-31), PTH (1-34), PTH (1-37), PTH (1-38) Y PTH (1-41).3.- Una composición farmacéutica de acuerdo con la reivindicación 1, en donde PTH es PTH (1-34).4.- Una composición farmacéutica de acuerdo con la reivindicación 1, en donde la PTH es PTH recombinante.5.- Una composición farmacéutica de acuerdo con la reivindicación 3, en donde la PTH es PTH recombinante.6.- Una composición farmacéutica de acuerdo con la reivindicación 1, en donde la PTH es hormona paratiroides humana.7.- Una composición farmacéutica de acuerdo con la reivindicación 6, en donde la hormona paratiroides humana es hPTH (1-34).8.- Una composición farmacéutica de acuerdo con la reivindicación 1, en donde el 5-CNAC se selecciona del ácido libre, la sal disódica de ácido N-(5-clorosaliciloil)-8-aminocaprílico y su monohidrato.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US31304801P | 2001-08-17 | 2001-08-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
CO5560586A2 true CO5560586A2 (es) | 2005-09-30 |
Family
ID=23214149
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO04013136A CO5560586A2 (es) | 2001-08-17 | 2004-02-17 | Acido n-(5-clorosaliciloil)-8-aminocaprilico como agente de suministro oral para fragmentos de hormona paratiroides |
Country Status (26)
Country | Link |
---|---|
US (4) | US20040242478A1 (es) |
EP (1) | EP1420827B8 (es) |
JP (2) | JP4959917B2 (es) |
KR (1) | KR20040030120A (es) |
CN (1) | CN1279981C (es) |
AT (1) | ATE443527T1 (es) |
AU (1) | AU2002333443C1 (es) |
BR (1) | BRPI0211932B1 (es) |
CA (1) | CA2453646C (es) |
CO (1) | CO5560586A2 (es) |
CY (1) | CY1109661T1 (es) |
DE (1) | DE60233803D1 (es) |
DK (1) | DK1420827T3 (es) |
EC (1) | ECSP044961A (es) |
ES (1) | ES2333587T3 (es) |
HU (1) | HUP0401441A3 (es) |
IL (2) | IL159714A0 (es) |
MX (1) | MXPA04001418A (es) |
NO (1) | NO328069B1 (es) |
NZ (1) | NZ531018A (es) |
PL (1) | PL210258B1 (es) |
PT (1) | PT1420827E (es) |
RU (1) | RU2322256C2 (es) |
SI (1) | SI1420827T1 (es) |
WO (1) | WO2003015822A1 (es) |
ZA (1) | ZA200400242B (es) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101837120A (zh) * | 2001-06-01 | 2010-09-22 | 诺瓦提斯公司 | 口服施用甲状旁腺激素和降钙素 |
NZ531018A (en) * | 2001-08-17 | 2006-03-31 | Novartis Ag | 5-CNAC as oral delivery agent for parathyroid hormone fragments |
DE60318192T2 (de) * | 2002-04-10 | 2008-04-30 | The University Of Virginia Patent Foundation | Verwendung von a2a adenosin rezeptor agonisten und anti-pathogene mittel enthaltenden kombinationen zur behandlung von entzündungskrankheiten |
US20050054557A1 (en) * | 2002-05-09 | 2005-03-10 | Goldberg Michael M. | Compositions for delivering parathyroid hormone and calcitonin |
PT2316473E (pt) | 2003-07-23 | 2013-09-20 | Novartis Ag | Utilização de calcitonina na osteoartrite |
GB0427600D0 (en) * | 2004-12-16 | 2005-01-19 | Novartis Ag | Organic compounds |
US8110547B2 (en) * | 2005-01-12 | 2012-02-07 | Emisphere Technologies, Inc. | Compositions for buccal delivery of parathyroid hormone |
EP1896134A2 (en) * | 2005-06-13 | 2008-03-12 | Rigel Pharmaceuticals, Inc. | Methods and compositions for treating degenerative bone disorders |
EP1937627A4 (en) | 2005-09-19 | 2010-09-01 | Emisphere Tech Inc | CRYSTALLINE FORMS OF N-(5-CHLOROSALICYLOYL) -8-AMINOCAPRYL ACETATE |
GB0522566D0 (en) * | 2005-11-04 | 2005-12-14 | Novartis Ag | Organic compounds |
EP1945245A2 (en) * | 2005-11-10 | 2008-07-23 | The Board of Control of Michigan Technological University | Black bear parathyroid hormone and methods of using black bear parathyroid hormone |
JP5042312B2 (ja) * | 2006-08-31 | 2012-10-03 | ノバルティス アーゲー | Hghを含む経口送達用医薬組成物 |
PL2131810T3 (pl) * | 2007-03-02 | 2011-09-30 | Novartis Ag | Podawanie doustne kalcytoniny |
NZ585080A (en) | 2007-11-02 | 2012-05-25 | Emisphere Tech Inc | Composition comprising Vitamin B12 and N-[8-(2-hydroxybenzoyl) amino ]caprylic acid and salts thereof for treating Vitamin B12 deficiency |
JP2013512688A (ja) | 2009-12-07 | 2013-04-18 | ミシガン テクノロジカル ユニバーシティ | クロクマの副甲状腺ホルモン及びクロクマの副甲状腺ホルモンを使用する方法 |
WO2012130193A1 (en) | 2011-03-31 | 2012-10-04 | Zentiva, K.S. | Non-covalent soluble complexes of teriparatide with polysaccharides and a dosage form of teriparatide for oral administration |
IL253802B (en) * | 2015-02-09 | 2022-06-01 | Entera Bio Ltd | A preparation for the treatment of osteoporosis |
KR101796604B1 (ko) * | 2016-08-30 | 2017-11-10 | 목포대학교 산학협력단 | 위장관 흡수증진제를 함유하는 부갑상선 호르몬의 경구 투여 제형 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4692433A (en) * | 1983-10-12 | 1987-09-08 | The Regents Of The University Of California | Method and composition for regulating serum calcium levels of mammals |
EP0618805A1 (en) * | 1991-12-17 | 1994-10-12 | PROCTER & GAMBLE PHARMACEUTICALS, INC. | Methods for the treatment of osteoporosis using bisphosphonates and parathyroid hormone |
JP3717925B2 (ja) * | 1992-09-29 | 2005-11-16 | ネクター セラピューティクス | 副甲状腺ホルモンの活性フラグメントの肺導入 |
US5773647A (en) * | 1997-02-07 | 1998-06-30 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
DK0993831T3 (da) * | 1997-02-07 | 2008-03-25 | Emisphere Tech Inc | Forbindelser og præparater til tilförsel af aktive stoffer |
JP2003533167A (ja) * | 1998-11-25 | 2003-11-11 | ザ ゼネラル ホスピタル コーポレーション | アミノ末端改変副甲状腺ホルモン(pth)アナログ |
NZ534409A (en) * | 1999-04-05 | 2006-03-31 | Emisphere Tech Inc | Disodium salts, monohydrates, and ethanol solvates for delivering active agents |
ES2386263T3 (es) * | 2000-03-21 | 2012-08-14 | Emisphere Technologies, Inc. | Método de preparación de salicilamidas alquiladas mediante un producto intermedio de dicarboxilato |
CN101837120A (zh) | 2001-06-01 | 2010-09-22 | 诺瓦提斯公司 | 口服施用甲状旁腺激素和降钙素 |
NZ531018A (en) * | 2001-08-17 | 2006-03-31 | Novartis Ag | 5-CNAC as oral delivery agent for parathyroid hormone fragments |
EP1651248B1 (en) * | 2003-07-11 | 2009-09-09 | Novartis AG | Orally dosed pharmaceutical compositions comprising a delivery agent in micronized form |
-
2002
- 2002-08-16 NZ NZ531018A patent/NZ531018A/xx not_active IP Right Cessation
- 2002-08-16 SI SI200230866T patent/SI1420827T1/sl unknown
- 2002-08-16 DE DE60233803T patent/DE60233803D1/de not_active Expired - Lifetime
- 2002-08-16 PT PT02794796T patent/PT1420827E/pt unknown
- 2002-08-16 PL PL365388A patent/PL210258B1/pl unknown
- 2002-08-16 JP JP2003520780A patent/JP4959917B2/ja not_active Expired - Fee Related
- 2002-08-16 DK DK02794796T patent/DK1420827T3/da active
- 2002-08-16 CN CNB028160843A patent/CN1279981C/zh not_active Expired - Fee Related
- 2002-08-16 AU AU2002333443A patent/AU2002333443C1/en not_active Ceased
- 2002-08-16 AT AT02794796T patent/ATE443527T1/de active
- 2002-08-16 WO PCT/EP2002/009181 patent/WO2003015822A1/en active Application Filing
- 2002-08-16 MX MXPA04001418A patent/MXPA04001418A/es active IP Right Grant
- 2002-08-16 IL IL15971402A patent/IL159714A0/xx unknown
- 2002-08-16 BR BRPI0211932A patent/BRPI0211932B1/pt not_active IP Right Cessation
- 2002-08-16 KR KR10-2004-7002277A patent/KR20040030120A/ko active Search and Examination
- 2002-08-16 EP EP02794796A patent/EP1420827B8/en not_active Expired - Lifetime
- 2002-08-16 ES ES02794796T patent/ES2333587T3/es not_active Expired - Lifetime
- 2002-08-16 US US10/484,331 patent/US20040242478A1/en not_active Abandoned
- 2002-08-16 RU RU2004107899/15A patent/RU2322256C2/ru not_active IP Right Cessation
- 2002-08-16 HU HU0401441A patent/HUP0401441A3/hu unknown
- 2002-08-16 CA CA002453646A patent/CA2453646C/en not_active Expired - Lifetime
-
2004
- 2004-01-05 IL IL159714A patent/IL159714A/en not_active IP Right Cessation
- 2004-01-13 ZA ZA200400242A patent/ZA200400242B/en unknown
- 2004-01-29 EC EC2004004961A patent/ECSP044961A/es unknown
- 2004-02-10 NO NO20040598A patent/NO328069B1/no not_active IP Right Cessation
- 2004-02-17 CO CO04013136A patent/CO5560586A2/es not_active Application Discontinuation
-
2006
- 2006-05-30 US US11/443,528 patent/US20060217313A1/en not_active Abandoned
-
2009
- 2009-06-09 JP JP2009138067A patent/JP2009242410A/ja not_active Withdrawn
- 2009-07-01 US US12/495,966 patent/US20090264367A1/en not_active Abandoned
- 2009-11-25 CY CY20091101231T patent/CY1109661T1/el unknown
-
2011
- 2011-12-15 US US13/327,114 patent/US9272040B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO5560586A2 (es) | Acido n-(5-clorosaliciloil)-8-aminocaprilico como agente de suministro oral para fragmentos de hormona paratiroides | |
EA199901025A1 (ru) | Пептидные аналоги паратиреоидного гормона | |
DE69938064D1 (de) | Aminoterminal modifizierte parathyroidhormon (pth) analoge | |
TW200626613A (en) | Analogues of GLP-1 | |
HRP20201353T1 (hr) | Agonisti glukagonskog receptora | |
RS49707B (sr) | Primena polipeptidnog analoga peptida srodnog paratireoidnom hormonu i njegovih soli za proizvodnju medikamenata za lečenje preloma kostiju | |
DE69739912D1 (de) | Parathyroidhormon Analoge | |
ATE250425T1 (de) | Analoga des parathyroid-hormons | |
JP2005501852A5 (es) | ||
RU2000109305A (ru) | ЗАЖИВЛЕНИЕ ПЕРЕЛОМОВ С ПОМОЩЬЮ АНАЛОГОВ ПЕПТИДА, ПОДОБНОГО ПАРАТИРЕОИДНОМУ ГОРМОНУ (РТНrР) | |
ES2190244T3 (es) | Uso de la hormona paratiroidea constituida por una secuencia de aminoacidos 1-34 de la hormona paratiroidea humana para reducir el riesco de fracturas oseas vertebrales y no vertebrales. | |
CA2369591A1 (en) | Disodium salts, monohydrate, and ethanol solvates | |
DK1137666T3 (da) | GLP-1-analoger | |
BR9811094A (pt) | Agente terapêutico para tumores linfáticos | |
DE3481306D1 (de) | Biologisch wirksame peptide strukturell mit regionen von wachstumshormonen in verbindung stehend. | |
UY24651A1 (es) | Método para la síntesis de analogos de la hormona paratiroidea y del peptido relacionado con la hormona paratiroidea. | |
US20150011473A1 (en) | Stabilized pth formulation | |
CL2004001579A1 (es) | Composicion farmaceutica que comprende un analogo de somatostatina y acido tartarico, donde la composicion tiene el ph regulado entre 4 y 4,5 y el compuesto activo es l ciclo[{4-(nh2-c2h4-nh-cp-o)pro}-phg-dtrp-lys-tyr(4-bzl)-phe]; y su uso para prepa | |
ES2122921B1 (es) | Proteinas recombinantes de fusion del virus reproductivo y respiratorio porcino (prrsv) y su empleo en diagnostico. | |
ECSP972207A (es) | Metodo para la sintesis de analogos de la hormona paratiroidea y del peptido relacionado con la hormona paratiroidea (caso ran 4105/190) | |
ES2101017T3 (es) | Antagonistas de bradiquinina para el tratamiento de pancreatitis aguda. | |
RU2001106603A (ru) | Соединения и композиции для доставки активных средств | |
EA200100801A1 (ru) | Применение половых гормонов при изготовлении фармацевтической композиции для назального введения, предназначенной для лечения нежелательного маточного кровотечения | |
BR9812265A (pt) | Uso de análogos de gaba, tais como gabapentina, na fabricação de um medicamento para o tratamento de doenças inflamatórias. | |
UY26365A1 (es) | Sales de disodio, monohidratos, solvatos de etanol para la liberación de agentes activos |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Application refused |